Correlation Between Prostate-specific Membrane Antigen Positron Emission Tomography and Arterial Spin Labeling Perfusion Imaging in Glioblastoma

Similarity of Biological Information Captured by (68)Gallium-prostate Specific Membrane Antigen-11 Positron Emission Tomography and Arterial Spin Labeling Perfusion Imaging in Glioblastoma

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06600399

Acronym

PSMA，ASL，PET

Enrollment

Registered

2024-09-19

Start date

2022-10-01

Completion date

2024-02-29

Last updated

2024-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glioblastoma

Keywords

Prostate-specific membrane antigen, Arterial spin labeling

Brief summary

Evaluating the relationship between prostate-specific membrane antigen positron emission tomography and arterial spin labeling perfusion imaging, and the correlation with prostate-specific membrane antigen expressed on glioblastoma microvascular.

Interventions

DIAGNOSTIC_TESTglioblastoma

All patients underwent conventional MRI, ASL perfusion imaging and 68Ga-PSMA-11 PET/CT examinations within 1 week interval

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Newly diagnosed or recurrent glioblastoma; * Adult (≥18 years old);

Exclusion criteria

* The patient has a serious underlying disease or mental illness and is unable to cooperate with the imaging examination; * Have received systematic chemotherapy; * The image data is of poor or incomplete quality; * pregnant women;

Design outcomes

Primary

Measure	Time frame	Description
The similarity of biological information	2 week	Evaluating the similarity of biological information captured by prostate-specific membrane antigen positron emission tomography and arterial spin labeling perfusion imaging in glioblastoma.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026